Form 4: Globus Medical Director Gifts 6,100 Shares
Insider Transaction Report
Globus Medical Director David D. Davidar reported gifting 6,100 shares of Class A Common Stock to a family trust.
Summary
- David D. Davidar, a Director of Globus Medical Inc. (GMED), reported a change in beneficial ownership.
- On January 2, 2025, Mr. Davidar disposed of 6,100 shares of Class A Common Stock through a gift (Transaction Code 'G').
- The shares were gifted at a price of $0 per share.
- Following this transaction, Mr. Davidar directly beneficially owns 510,175 shares of Class A Common Stock.
- Additionally, Mr. Davidar indirectly beneficially owns 165,967 shares of Class A Common Stock held in the Davidar Family Irrevocable Trust U/A 8/6/09.
- The trust benefits the reporting person's spouse and children, with the spouse serving as trustee.
Sentiment
Score: 5
Explanation: The filing reports a routine insider gift transaction, which is generally neutral in sentiment. It does not convey positive or negative operational or financial news for the company.
Negatives
- Direct beneficial ownership of Class A Common Stock by Director David D. Davidar decreased by 6,100 shares due to a gift.
Industry Context
This filing is a routine disclosure of an insider transaction, common across all publicly traded companies, and does not provide specific insights into broader industry trends or competitive landscape for medical devices.
Related Party Transactions
- The 6,100 shares were gifted to a trust for the benefit of the reporting person's spouse and children, with the spouse acting as trustee. An additional 165,967 shares are indirectly held in this trust.
Stakeholder Impact
- Shareholders: Minimal direct impact, as it represents a small reduction in direct insider ownership, but the shares remain within the insider's family control via a trust.
- Employees, Customers, Suppliers, Creditors: No direct impact from this insider transaction.
Key Dates
| Date | Description |
|---|---|
| 01/02/2025 | Date of the reported gift transaction of Class A Common Stock. |
| 01/02/2026 | Date indicated in the filing header as the 'Date of Earliest Transaction' (note: this date is inconsistent with the actual transaction date of 01/02/2025 in Table I). |
| 01/05/2026 | Date the Form 4 was signed and filed with the SEC. |
Keywords
GLOBUS MEDICAL INC, GMED, Form 4, Insider Transaction, Stock Gift, Director, Davidar, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.